Page last updated: 2024-10-26

dimercaprol and Multiple Sclerosis

dimercaprol has been researched along with Multiple Sclerosis in 3 studies

Dimercaprol: An anti-gas warfare agent that is effective against Lewisite (dichloro(2-chlorovinyl)arsine) and formerly known as British Anti-Lewisite or BAL. It acts as a chelating agent and is used in the treatment of arsenic, gold, and other heavy metal poisoning.
dimercaprol : A dithiol that is propane-1,2-dithiol in which one of the methyl hydrogens is replaced by a hydroxy group. a chelating agent originally developed during World War II as an experimental antidote against the arsenic-based poison gas Lewisite, it has been used clinically since 1949 for the treatment of poisoning by arsenic, mercury and gold. It can also be used for treatment of poisoning by antimony, bismuth and possibly thallium, and (with sodium calcium edetate) in cases of acute leaad poisoning. Administration is by (painful) intramuscular injection of a suspension of dimercaprol in peanut oil, typically every 4 hours for 2-10 days depending on the toxicity. In the past, dimercaprol was also used for the treatment of Wilson's disease, a severely debilitating genetic disorder in which the body tends to retain copper, with resultant liver and brain injury.

Multiple Sclerosis: An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
DANILO, D1
Nardini, L1

Other Studies

3 other studies available for dimercaprol and Multiple Sclerosis

ArticleYear
[Treatment of multiple sclerosis with BAL].
    Minerva medica, 1950, Oct-13, Volume: 41, Issue:50

    Topics: Dimercaprol; Humans; Multiple Sclerosis; Sclerosis

1950
[New trends in the treatment of multiple sclerosis with BAL tetraethylammonium vitamin B12].
    La Presse medicale, 1951, Feb-07, Volume: 59, Issue:8

    Topics: Corrinoids; Dimercaprol; Hematinics; Humans; Multiple Sclerosis; Sclerosis; Tetraethylammonium; Vita

1951
[B.A.L. in the clinico-therapeutic experience of multiple sclerosis. (Some results)].
    Rivista sperimentale di freniatria e medicina legale delle alienazioni mentali, 1966, Apr-30, Volume: 90, Issue:2

    Topics: Adult; Dimercaprol; Female; Humans; Male; Middle Aged; Multiple Sclerosis

1966